Geode Capital Management’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,680
Closed -$298K 4728
2023
Q4
$298K Buy
50,680
+4,489
+10% +$53.1K ﹤0.01% 3809
2023
Q3
$1.17M Buy
46,191
+3,001
+7% +$247K ﹤0.01% 3258
2023
Q2
$6M Buy
43,190
+11,391
+36% +$1.46M ﹤0.01% 2587
2023
Q1
$2.89M Buy
31,799
+1,429
+5% +$194K ﹤0.01% 2878
2022
Q4
$4.16M Buy
30,370
+1,418
+5% +$480K ﹤0.01% 2755
2022
Q3
$25.1M Sell
28,952
-799
-3% -$501K ﹤0.01% 1567
2022
Q2
$13M Buy
29,751
+14,339
+93% +$7.48M ﹤0.01% 2068
2022
Q1
$9.79M Buy
15,412
+536
+4% +$338K ﹤0.01% 2357
2021
Q4
$13.3M Buy
14,876
+1,218
+9% +$1.28M ﹤0.01% 2239
2021
Q3
$17.3M Buy
+13,658
New +$16.6M ﹤0.01% 2055

Other funds holding CANO

Geode Capital Management's CANO Position: Q1 2024 in Review

Geode Capital Management sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 50,680 shares — an estimated $298K sold.

Geode Capital Management first reported a position in CANO in Q3 2021 and held it in 10 quarters. The position peaked at $25.1M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Geode Capital Management reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 50,680 Cano Health, Inc. shares in Q1 2024, an estimated $298K.
  • Geode Capital Management first reported a position in Cano Health, Inc. in Q3 2021 and held it in 10 quarters.
  • Geode Capital Management's Cano Health, Inc. position peaked at $25.1M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.